United States Biotechnology & Medical Research

Revance Therapeutics Inc (RVNC)

Track

Ticker: RVNC Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Revance Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 18 Nov 2024
Value US$2,660,279.77 | Price 99.75 | Shares 66,215 (+11.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-19 2024-11-18 S Sale
Hollander David

CMO & Global Therapeutics Lead

Officer
66,215 +11.2%
99.75
US$2,660,280 		66,215 +11.2% 99.75 US$2,660,280
2024-04-17 2024-04-16 S Sale
1.7
Jordan Erica

Chief Commercial Officer

Officer
44,421 +33.8%
139.77
US$4,529,635 		44,421 +33.8% 139.77 US$4,529,635
2024-03-19 2024-03-18 S Sale
3.8
Moxie Dwight

CLO & GC

Officer
74,461 -18.5%
415.28
US$92,020 		74,461 -18.5% 415.28 US$92,020
2024-03-19 2024-03-18 S Sale
3.8
Schilke Tobin

CFO

Officer
9,361 -4.6%
5.04
US$47,204 		9,361 -4.6% 5.04 US$47,204
2024-03-19 2024-03-18 S Sale
3.7
Sjuts Dustin S

President

Officer
9,211 -5.2%
5.04
US$46,446 		9,211 -5.2% 5.04 US$46,446
2024-03-18 2024-03-15 PrS Proposed sale
3.7
Dustin Sjuts

Officer

Officer
9,500
5.53
US$52,500 		9,500 5.53 US$52,500
2024-03-18 2024-03-15 PrS Proposed sale
3.8
Tobin Schilke

Officer

Officer
9,500
5.53
US$52,500 		9,500 5.53 US$52,500
2024-03-18 2024-03-15 PrS Proposed sale
3.8
Dwight Moxie

Officer

Officer
8,500
5.50
US$46,750 		8,500 5.50 US$46,750
2024-03-08 2024-03-06 B Purchase
3.5
Foley Mark J

CEO

Executive Director
30,000 +3.0%
6.98
US$209,400 		30,000 +3.0% 6.98 US$209,400
2023-09-07 2023-09-06 PlS Planned sale
3.8
Moxie Dwight

SVP, GC & Secretary

Officer
11,000 -20.0%
17.06
US$187,704 		11,000 -20.0% 17.06 US$187,704
2023-09-06 2023-09-06 PrS Proposed sale
3.8
DWIGHT MOXIE

Officer

Officer
11,000
17.06
US$187,704 		11,000 17.06 US$187,704
2023-09-07 2023-09-05 PlS Planned sale
3.8
Moxie Dwight

SVP, GC & Secretary

Officer
23,853 -30.2%
17.81
US$424,920 		23,853 -30.2% 17.81 US$424,920
2023-09-05 2023-09-05 PrS Proposed sale
3.8
DWIGHT MOXIE

Officer

Officer
23,853
17.81
US$424,917 		23,853 17.81 US$424,917
2023-08-04 2023-08-03 PlS Planned sale
3.5
Foley Mark J

CEO

Executive Director
26,279 -3.0%
22.57
US$593,151 		26,279 -3.0% 22.57 US$593,151
2023-08-03 2023-08-03 PrS Proposed sale
3.5
MARK FOLEY

Officer; Director

Executive Director
26,279
22.49
US$591,115 		26,279 22.49 US$591,115
2023-07-05 2023-07-03 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
1,701 -2.1%
25.04
US$42,593 		1,701 -2.1% 25.04 US$42,593
2023-07-05 2023-07-03 PlS Planned sale
3.5
Foley Mark J

CEO

Executive Director
26,279 -2.9%
24.94
US$655,333 		26,279 -2.9% 24.94 US$655,333
2023-07-03 2023-07-03 PrS Proposed sale
3.5
MARK FOLEY

Officer; Director

Executive Director
26,279
24.94
US$655,398 		26,279 24.94 US$655,398
2023-07-03 2023-07-03 PrS Proposed sale
3.8
TOBIN SCHILKE

Officer

Officer
1,701
25.04
US$42,593 		1,701 25.04 US$42,593
2023-06-20 2023-06-15 PlS Planned sale
Kolaja Carey OConnor
Non-Executive Director
2,500 -13.1%
28.24
US$70,600 		2,500 -13.1% 28.24 US$70,600
2023-06-15 2023-06-15 PrS Proposed sale
CAREY KOLAJA

Director

Non-Executive Director
2,500
28.24
US$70,600 		2,500 28.24 US$70,600
2023-06-13 2023-06-09 PlS Planned sale
3.5
Foley Mark J

CEO

Executive Director
31,279 -3.4%
30.72
US$960,928 		31,279 -3.4% 30.72 US$960,928
2023-06-13 2023-06-09 PlS Planned sale
3.7
Sjuts Dustin S

President

Officer
5,000 -3.3%
30.82
US$154,096 		5,000 -3.3% 30.82 US$154,096
2023-06-09 2023-06-09 PrS Proposed sale
3.7
DUSTIN SJUTS

Officer

Officer
5,000
30.82
US$154,096 		5,000 30.82 US$154,096
2023-06-09 2023-06-09 PrS Proposed sale
3.5
MARK FOLEY

Officer; Director

Executive Director
31,279
30.72
US$960,901 		31,279 30.72 US$960,901
2023-06-05 2023-06-02 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
500 -0.6%
31.00
US$15,500 		500 -0.6% 31.00 US$15,500
2023-06-02 2023-06-02 PrS Proposed sale
3.8
TOBIN SCHILKE

Officer

Officer
500
31.00
US$15,500 		500 31.00 US$15,500
2023-06-05 2023-06-01 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
2,701 -3.2%
30.57
US$82,570 		2,701 -3.2% 30.57 US$82,570
2023-06-01 2023-06-01 PrS Proposed sale
3.8
TOBIN SCHILKE

Officer

Officer
2,701
30.57
US$82,570 		2,701 30.57 US$82,570
2023-05-16 2023-05-15 S Sale
3.8
Schilke Tobin

CFO

Officer
21,401 -20.3%
34.55
US$739,338 		21,401 -20.3% 34.55 US$739,338
2023-05-16 2023-05-15 S Sale
3.8
Moxie Dwight

SVP, GC & Secretary

Officer
21,401 -23.6%
34.55
US$739,338 		21,401 -23.6% 34.55 US$739,338
2023-05-16 2023-05-15 S Sale
3.7
Sjuts Dustin S

President

Officer
21,015 -12.1%
34.55
US$726,003 		21,015 -12.1% 34.55 US$726,003
2023-05-16 2023-05-15 S Sale
3.5
Foley Mark J

CEO

Executive Director
70,447 -7.1%
34.55
US$2,433,725 		70,447 -7.1% 34.55 US$2,433,725
2023-05-15 2023-05-15 PrS Proposed sale
3.5
Mark Foley

Officer

Officer
447
34.56
US$15,450 		447 34.56 US$15,450
2023-05-12 2023-05-12 PrS Proposed sale
3.8
Dwight Moxie

Officer

Officer
22,000
33.40
US$734,800 		22,000 33.40 US$734,800
2023-05-12 2023-05-12 PrS Proposed sale
3.7
Dustin Sjuts

Officer

Officer
22,000
33.40
US$734,800 		22,000 33.40 US$734,800
2023-05-12 2023-05-12 PrS Proposed sale
3.8
Tobin Schilke

Officer

Officer
22,000
33.40
US$734,800 		22,000 33.40 US$734,800
2023-05-12 2023-05-12 PrS Proposed sale
3.5
Mark Foley

Officer

Officer
70,000
33.40
US$2,338,000 		70,000 33.40 US$2,338,000
2023-05-02 2023-05-01 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
3,201 -4.8%
31.70
US$101,472 		3,201 -4.8% 31.70 US$101,472
2023-05-01 2023-05-01 PrS Proposed sale
3.8
TOBIN SCHILKE

Officer

Officer
3,201
31.70
US$101,472 		3,201 31.70 US$101,472
2023-04-04 2023-04-03 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
3,201 -4.6%
32.15
US$102,912 		3,201 -4.6% 32.15 US$102,912
2023-03-09 2023-03-09 S Sale
3.5
Foley Mark J

CEO

Executive Director
70,390 -7.9%
31.59
US$2,223,360 		70,390 -7.9% 31.59 US$2,223,360
2023-03-09 2023-03-09 S Sale
3.8
Moxie Dwight

SVP, GC & Secretary

Officer
18,496 -25.0%
31.59
US$584,220 		18,496 -25.0% 31.59 US$584,220
2023-03-09 2023-03-09 S Sale
3.7
Sjuts Dustin S

President

Officer
21,508 -14.8%
31.59
US$679,358 		21,508 -14.8% 31.59 US$679,358
2023-03-09 2023-03-09 S Sale
3.8
Schilke Tobin

CFO

Officer
18,517 -20.2%
31.59
US$584,884 		18,517 -20.2% 31.59 US$584,884
2023-03-09 2023-03-08 PrS Proposed sale
3.8
Tobin Schilke

Officer

Officer
20,000
33.00
US$660,000 		20,000 33.00 US$660,000
2023-03-09 2023-03-08 PrS Proposed sale
3.8
Dwight Moxie

Officer

Officer
20,000
33.00
US$660,000 		20,000 33.00 US$660,000
2023-03-09 2023-03-08 PrS Proposed sale
3.5
Mark Foley

Officer

Officer
75,000
33.00
US$2,475,000 		75,000 33.00 US$2,475,000
2023-03-09 2023-03-08 PrS Proposed sale
3.7
Dustin Sjuts

Officer

Officer
23,000
33.00
US$759,000 		23,000 33.00 US$759,000
2023-03-02 2023-03-01 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
3,201 -6.1%
33.50
US$107,234 		3,201 -6.1% 33.50 US$107,234
2023-02-02 2023-02-01 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
3,201 -5.5%
34.60
US$110,755 		3,201 -5.5% 34.60 US$110,755
2023-01-23 2023-01-20 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
1,000 -1.7%
31.00
US$31,000 		1,000 -1.7% 31.00 US$31,000
2023-01-10 2023-01-09 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
1,000 -1.7%
30.00
US$30,000 		1,000 -1.7% 30.00 US$30,000
2023-01-10 2023-01-09 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
1,000 -1.6%
28.00
US$28,000 		1,000 -1.6% 28.00 US$28,000
2023-01-10 2023-01-09 PlS Planned sale
3.8
Schilke Tobin

CFO

Officer
1,701 -2.7%
25.00
US$42,525 		1,701 -2.7% 25.00 US$42,525
2022-09-16 2022-09-14 PlS Planned sale
3.8
Moxie Dwight

SVP, GC & Secretary

Officer
11,000 -25.8%
27.07
US$297,798 		11,000 -25.8% 27.07 US$297,798
2021-12-15 2021-12-13 B Purchase
1.4
Russell Angus C.
Non-Executive Director
6,400 +31.2%
15.74
US$100,741 		6,400 +31.2% 15.74 US$100,741
2021-12-06 2021-12-03 B Purchase
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
30,000 +45.8%
14.43
US$432,876 		30,000 +45.8% 14.43 US$432,876
2021-11-29 2021-11-29 B Purchase
3.5
Foley Mark J

CEO

Executive Director
40,000 +56.4%
12.90
US$515,924 		40,000 +56.4% 12.90 US$515,924
2021-09-28 2021-09-27 PlS Planned sale
3.8
Moxie Dwight

SVP, GC & Secretary

Officer
1,675 -3.4%
30.00
US$50,250 		1,675 -3.4% 30.00 US$50,250
2021-04-06 2021-04-05 PlS Planned sale
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
2 -0.0%
28.28
US$57 		2 -0.0% 28.28 US$57
2021-03-05 2021-03-04 PlS Planned sale
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
33,119 -7.5%
25.43
US$842,216 		33,119 -7.5% 25.43 US$842,216
2021-02-03 2021-02-01 PlS Planned sale
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
33,119 -6.9%
25.95
US$859,438 		33,119 -6.9% 25.95 US$859,438
2021-01-04 2020-12-30 PlS Planned sale
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
33,119 -6.5%
27.82
US$921,212 		33,119 -6.5% 27.82 US$921,212
2020-12-02 2020-11-30 PlS Planned sale
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
33,119 -6.1%
23.85
US$789,888 		33,119 -6.1% 23.85 US$789,888
2020-10-30 2020-10-29 PlS Planned sale
3.1
Rankin Aubrey

President, Innovation & Tech

Executive Director
33,119 -5.7%
26.15
US$865,949 		33,119 -5.7% 26.15 US$865,949
2019-03-19 2019-03-18 PlS Planned sale
Browne L Daniel

CEO and President

Executive Director
11,613 -7.1%
15.51
US$180,068 		11,613 -7.1% 15.51 US$180,068
2019-03-19 2019-03-18 PlS Planned sale
Allouche Cyril

Principal Accounting Officer
498 -7.2%
15.48
US$7,709 		498 -7.2% 15.48 US$7,709
2019-02-20 2019-02-19 PlS Planned sale
Browne L Daniel

CEO and President

Executive Director
5,446 -3.1%
17.68
US$96,285 		5,446 -3.1% 17.68 US$96,285
2019-01-23 2019-01-22 PlS Planned sale
Allouche Cyril

Principal Accounting Officer

Officer
625 -13.5%
17.77
US$11,106 		625 -13.5% 17.77 US$11,106
2019-01-04 2019-01-03 PlS Planned sale
Allouche Cyril

Principal Accounting Officer

Officer
375 -8.6%
19.48
US$7,305 		375 -8.6% 19.48 US$7,305
2018-11-21 2018-11-20 PlS Planned sale Allouche Cyril

Principal Accounting Officer

Officer
491 -10.9%
20.66
US$10,144 		491 -10.9% 20.66 US$10,144
2018-11-09 2018-11-09 PlS Planned sale Allouche Cyril

Principal Accounting Officer

Officer
2,188 -31.5%
23.72
US$51,899 		2,188 -31.5% 23.72 US$51,899
2018-07-06 2018-07-06 PlS Planned sale Allouche Cyril

Principal Financial Officer

Officer
393 -7.6%
28.35
US$11,142 		393 -7.6% 28.35 US$11,142
2018-05-24 2018-05-22 PlS Planned sale SILVERNAIL LAUREN P

CFO & CBO

Officer
2,874 -4.2%
30.25
US$86,924 		2,874 -4.2% 30.25 US$86,924
Explore more

More insider trading research around Revance Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America